Although recent meta-analysis and a multi-center study reported no association between K-ras mutations and CRC patients’ prognosis could not be indicated, the largest study focused on this issue, the RASCAL collaborative study, showed there might be connections between G12V mutation and poorer prognosis [11-13]. This evidence concerns the gene KRAS and colorectal carcinoma.